Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    July 2018
  1. CONNOLLY A, Grandi V, Stefanato CM, Palmer R, et al
    Primary cutaneous CD30(+) anaplastic large cell lymphoma associated with fingolimod.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17003.
    PubMed     Text format     Abstract available


    May 2018
  2. CHRISTENSEN L, Cooper K, Honda K, Mansur D, et al
    Relapse rates in patients with unilesional primary cutaneous B cell lymphoma treated with radiation therapy: a single-institution experience.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16783.
    PubMed     Text format     Abstract available


    March 2018
  3. MELCHERS RC, Willemze R, Bekkenk MW, de Haas ERM, et al
    Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16501.
    PubMed     Text format     Abstract available


    February 2018
  4. ORLOWSKA D, Selman LE, Beynon T, Radcliffe E, et al
    "It's a traumatic illness, traumatic to witness." A qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16447.
    PubMed     Text format     Abstract available


    January 2018
  5. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Text format     Abstract available


  6. HURABIELLE C, Leboeuf C, Ram-Wolff C, Meignin V, et al
    KIR3DL2 expression in patients with adult T-cell lymphoma/leukemia.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16322.
    PubMed     Text format     Abstract available


    December 2017
  7. KAMSTRUP MR, Skov L, Zachariae C, Thyssen JP, et al
    Psoriasis and risk of malignant lymphoma: A population-based cohort study.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16245.
    PubMed     Text format     Abstract available


  8. GONZALEZ-QUESADA A, Bastida J, Rivero-Vera JC, Piris-Pinilla MA, et al
    Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    Br J Dermatol. 2017;177:e355.
    PubMed     Text format    


  9. SCARISBRICK JJ
    Brentuximab vedotin is an effective therapy for CD30(+) mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
    Br J Dermatol. 2017;177:1474-1475.
    PubMed     Text format    


  10. LUO Y, Liu J
    Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant.
    Br J Dermatol. 2017;177:e353.
    PubMed     Text format    


    November 2017
  11. CHEN L, Zhao X, Shi R, Zheng J, et al
    Image Gallery: Intravascular large B-cell lymphoma presenting with generalized telangiectasia.
    Br J Dermatol. 2017;177:e223.
    PubMed     Text format    


    October 2017
  12. GELLER S, Myskowski PL, Kim YH, Moskowitz A, et al
    The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: Are we there yet?
    Br J Dermatol. 2017 Oct 10. doi: 10.1111/bjd.16052.
    PubMed     Text format     Abstract available


    September 2017
  13. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma: reply from authors.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15972.
    PubMed     Text format     Abstract available


  14. LEWIS DJ, Kim YH, Duvic M
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15970.
    PubMed     Text format     Abstract available


  15. LIAW TY, Liang CW
    Image Gallery: Generalized annular figurate erythema as an unusual presentation of angioimmunoblastic T-cell lymphoma.
    Br J Dermatol. 2017;177:e75.
    PubMed     Text format    


  16. TENSEN CP, Vermeer MH
    MicroRNA-155 potentiates tumour development in mycosis fungoides.
    Br J Dermatol. 2017;177:618-620.
    PubMed     Text format    


    August 2017
  17. DE BRITO M, Gazzani P, Amel-Kashipaz R, Vydianath B, et al
    Image Gallery: Secondary cutaneous involvement of the ear with systemic small lymphocytic lymphoma: a rare manifestation.
    Br J Dermatol. 2017;177:e26.
    PubMed     Text format    


  18. DAWE RS
    Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate.
    Br J Dermatol. 2017;177:337-338.
    PubMed     Text format    


  19. VIEYRA-GARCIA P, Wolf P
    Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question.
    Br J Dermatol. 2017;177:336-337.
    PubMed     Text format    


    July 2017
  20. BAUER WM, Aichelburg MC, Griss J, Skrabs C, et al
    Molecular Classification of Tumor Cells in a Patient with Intravascular Large B-Cell Lymphoma.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15841.
    PubMed     Text format     Abstract available


  21. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat - How shall we treat? A review of the literature.
    Br J Dermatol. 2017 Jul 13. doi: 10.1111/bjd.15801.
    PubMed     Text format     Abstract available


  22. BAGOT M
    Folliculotropic mycosis fungoides is a heterogenous group.
    Br J Dermatol. 2017;177:17-18.
    PubMed     Text format    


    June 2017
  23. LEE WJ, Kim YJ, Lee YJ, Won CH, et al
    VEGF protein expression is associated with a poor prognosis in cutaneous extranodal NK/T-cell lymphoma patients.
    Br J Dermatol. 2017 Jun 9. doi: 10.1111/bjd.15720.
    PubMed     Text format     Abstract available


  24. ADAMSKI H, Ingen-Housz-Oro S, Machet L, Carriou AC, et al
    Lymphomatoid papulosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma: 3 cases.
    Br J Dermatol. 2017 Jun 1. doi: 10.1111/bjd.15698.
    PubMed     Text format     Abstract available


    May 2017
  25. SCARISBRICK JJ
    Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indices.
    Br J Dermatol. 2017;176:1129-1130.
    PubMed     Text format    


    April 2017
  26. KEMPF W
    Cutaneous lymphomas in childhood and adolescence: much needed new data.
    Br J Dermatol. 2017;176:857-858.
    PubMed     Text format    


    March 2017
  27. CHAN BC, Stefanato CM, Moonim MT, Morris SL, et al
    Diffuse large B-Cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: a case series.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15460.
    PubMed     Text format     Abstract available


    January 2017
  28. VAN SANTEN S, van Doorn R, Neelis KJ, Daniels LA, et al
    Recommendations for treatment in Folliculotropic Mycosis Fungoides: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15355.
    PubMed     Text format     Abstract available


    November 2016
  29. WOBSER M, Maurus K, Roth S, Appenzeller S, et al
    MYD88 mutations in a distinct type of cutaneous marginal zone lymphoma with a non-class switched IgM-immunophenotype.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15183.
    PubMed     Text format     Abstract available


    September 2016
  30. CHAN SA, Shah F, Chiganti S, Stevens A, et al
    Primary Cutaneous B-Cell Lymphoma - Systemic spread is rare whilst cutaneous relapses and secondary malignancies are frequent.
    Br J Dermatol. 2016 Sep 19. doi: 10.1111/bjd.15071.
    PubMed     Text format     Abstract available


    August 2016
  31. GRIJSEN ML, Mtayangulwa RG, Naafs B, Jansen P, et al
    The clinical spectrum of mycosis fungoides in Tanzania, East-Africa.
    Br J Dermatol. 2016 Aug 16. doi: 10.1111/bjd.14963.
    PubMed     Text format     Abstract available


  32. AMITAY-LAISH I, Tavallaee M, Kim J, Hoppe RT, et al
    Paediatric primary cutaneous marginal zone B-cell lymphoma: Does it differ from the adult counterpart?
    Br J Dermatol. 2016 Aug 8. doi: 10.1111/bjd.14932.
    PubMed     Text format     Abstract available


  33. KEMPF W
    TOX - what role does it play in cutaneous lymphomas?
    Br J Dermatol. 2016;175:248-9.
    PubMed     Text format    


  34. ORTIZ-ROMERO PL
    Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas.
    Br J Dermatol. 2016;175:246-7.
    PubMed     Text format    


    July 2016
  35. BATTISTELLA M, Salle de Chou C, de Bazelaire C, Cayuela JM, et al
    Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging.
    Br J Dermatol. 2016 Jul 5. doi: 10.1111/bjd.14850.
    PubMed     Text format     Abstract available


  36. SCARISBRICK JJ
    Cutaneous T-cell lymphomas: an urgent need for more improved therapies.
    Br J Dermatol. 2016;175:14-5.
    PubMed     Text format    


    May 2016
  37. CIZENSKI J, Griffin J, Menter A
    Image Gallery: Cutaneous T-cell lymphoma mimicking a gyrate erythema.
    Br J Dermatol. 2016;174:e42.
    PubMed     Text format    


  38. LECAMWASAM K, Mathew B, Gilson D, Burton C, et al
    Correspondence article regarding CD68 as a marker of CD8+ lymphoid proliferation suggested by Wobser et al.
    Br J Dermatol. 2016;174:1158-9.
    PubMed     Text format    


    April 2016
  39. BATTISTELLA M, Janin A, Jean-Louis F, Collomb C, et al
    KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large cell lymphoma.
    Br J Dermatol. 2016 Apr 1. doi: 10.1111/bjd.14626.
    PubMed     Text format     Abstract available


  40. SAWATKAR GU, Sahu KK, Prakash G, Dogra S, et al
    Image Gallery: Flagellate dermatitis.
    Br J Dermatol. 2016;174:e23.
    PubMed     Text format    


  41. FOO SH, Shah F, Chaganti S, Stevens A, et al
    Unmasking mycosis fungoides/Sezary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course.
    Br J Dermatol. 2016;174:901-4.
    PubMed     Text format    


    March 2016
  42. SIBBALD C, Pope E
    Systematic Review of Cases of Cutaneous T-Cell Lymphoma Transformation in Pityriasis Lichenoides and Small Plaque Parapsoriasis.
    Br J Dermatol. 2016 Mar 31. doi: 10.1111/bjd.14605.
    PubMed     Text format     Abstract available


  43. SANZ-BUENO J, Lora D, Monsalvez V, Maronas-Jimenez L, et al
    The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients.
    Br J Dermatol. 2016 Mar 15. doi: 10.1111/bjd.14559.
    PubMed     Text format     Abstract available


  44. SELLS RE, Chen CA, Wong MT, Zimarowski MJ, et al
    Continuous positive airway pressure-associated cutaneous amoebiasis in an immunosuppressed patient.
    Br J Dermatol. 2016;174:625-8.
    PubMed     Text format     Abstract available


  45. GAMBICHLER T, Mamali K, Patsinakidis N, Moritz R, et al
    Decreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides.
    Br J Dermatol. 2016;174:652-3.
    PubMed     Text format    


    January 2016
  46. FAHMY J, Halabi-Tawil M, Ram-Wolff C, Bagot M, et al
    Paraneoplastic acanthosis nigricans: the first reported case associated with Sezary syndrome.
    Br J Dermatol. 2016;174:233-4.
    PubMed     Text format    


    July 2015
  47. PICARD C, Gouarin S, Comoz F, Barreau M, et al
    Chronic active EBV infection with mainly cutaneous manifestation in a Caucasian woman with long-term follow-up.
    Br J Dermatol. 2015 Jul 4. doi: 10.1111/bjd.14014.
    PubMed     Text format     Abstract available


    June 2015
  48. SINHA R, Larkin J, Gore M, Fearfield L, et al
    Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF mutation-positive metastatic melanoma, including recognition and management of rare presentations.
    Br J Dermatol. 2015 Jun 24. doi: 10.1111/bjd.13958.
    PubMed     Text format     Abstract available


  49. GOODLAD JR
    Indolent CD8-positive lymphoid proliferation of acral sites: identifying the sheep in wolf's clothing.
    Br J Dermatol. 2015;172:1480-1.
    PubMed     Text format    


    January 2015
  50. DULMAGE BO, Feng H, Mirvish E, Geskin L, et al
    Black cat in a dark room: the absence of a directly oncogenic virus does not eliminate the role of an infectious agent in cutaneous T-cell lymphoma pathogenesis.
    Br J Dermatol. 2015;172:1449-51.
    PubMed     Text format    


  51. HOOGEDOORN L, Peppelman M, van de Kerkhof PC, van Erp PE, et al
    The value of in vivo reflectance confocal microscopy in the diagnosis and monitoring of inflammatory and infectious skin diseases: a systematic review.
    Br J Dermatol. 2015;172:1222-48.
    PubMed     Text format     Abstract available


    October 2014
  52. NICOLAE-CRISTEA AR, Benner MF, Zoutman WH, van Eijk R, et al
    Diagnostic and prognostic significance of CDKN2A/2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30+ lymphoproliferative disease.
    Br J Dermatol. 2014 Oct 11. doi: 10.1111/bjd.13476.
    PubMed     Text format     Abstract available


    August 2014
  53. SAINTES C, Saint-Jean M, Renaut JJ, Dreno B, et al
    Dramatic efficacy of brentuximab vedotin in 2 patients with epidermotropic cutaneous T-cell lymphomas after treatment failure despite variable CD30 expression.
    Br J Dermatol. 2014 Aug 12. doi: 10.1111/bjd.13337.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: